DCC-2721

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDCC-2721
Drug Alias Namec-Met kinase inhibitors (Deciphera)DP-4157DP-4756DP-3590DP-4693 +[6] 
ClassificationSmall molecules
Mechanisms of ActionHepatocyte growth factor receptor inhibitorsAnticancer protein kinase inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDeciphera Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDeciphera Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A